Literature DB >> 21558808

Vitamin D: a new player in the world of mTOR signaling.

Thomas S Lisse, Martin Hewison.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21558808      PMCID： PMC3154412          DOI： 10.4161/cc.10.12.15620

Source DB:  PubMed          Journal:  Cell Cycle        ISSN： 1551-4005            Impact factor:   4.534


× No keyword cloud information.
  11 in total

Review 1.  Growth control under stress: mTOR regulation through the REDD1-TSC pathway.

Authors:  Leif W Ellisen
Journal:  Cell Cycle       Date:  2005-11-01       Impact factor: 4.534

Review 2.  The mammalian target of rapamycin: linking T cell differentiation, function, and metabolism.

Authors:  Jonathan D Powell; Greg M Delgoffe
Journal:  Immunity       Date:  2010-09-24       Impact factor: 31.745

3.  Inhibition of mTORC1 by RAD001 (everolimus) potentiates the effects of 1,25-dihydroxyvitamin D(3) to induce growth arrest and differentiation of AML cells in vitro and in vivo.

Authors:  Jing Yang; Takayuki Ikezoe; Chie Nishioka; Lei Ni; H Phillip Koeffler; Akihito Yokoyama
Journal:  Exp Hematol       Date:  2010-04-09       Impact factor: 3.084

4.  Novel Gemini-vitamin D3 analog inhibits tumor cell growth and modulates the Akt/mTOR signaling pathway.

Authors:  James O'Kelly; Milan Uskokovic; Nathan Lemp; Jay Vadgama; H Phillip Koeffler
Journal:  J Steroid Biochem Mol Biol       Date:  2006-06-14       Impact factor: 4.292

5.  Gene targeting by the vitamin D response element binding protein reveals a role for vitamin D in osteoblast mTOR signaling.

Authors:  Thomas S Lisse; Ting Liu; Martin Irmler; Johannes Beckers; Hong Chen; John S Adams; Martin Hewison
Journal:  FASEB J       Date:  2010-12-01       Impact factor: 5.191

Review 6.  Vitamin D, disease and therapeutic opportunities.

Authors:  Lori A Plum; Hector F DeLuca
Journal:  Nat Rev Drug Discov       Date:  2010-12       Impact factor: 84.694

Review 7.  mTOR: from growth signal integration to cancer, diabetes and ageing.

Authors:  Roberto Zoncu; Alejo Efeyan; David M Sabatini
Journal:  Nat Rev Mol Cell Biol       Date:  2010-12-15       Impact factor: 94.444

8.  Rheb activates mTOR by antagonizing its endogenous inhibitor, FKBP38.

Authors:  Xiaochun Bai; Dongzhu Ma; Anling Liu; Xiaoyun Shen; Qiming J Wang; Yongjian Liu; Yu Jiang
Journal:  Science       Date:  2007-11-09       Impact factor: 47.728

Review 9.  Unexpected actions of vitamin D: new perspectives on the regulation of innate and adaptive immunity.

Authors:  John S Adams; Martin Hewison
Journal:  Nat Clin Pract Endocrinol Metab       Date:  2008-02

10.  Activation of the hypoxia-inducible factor-1alpha pathway accelerates bone regeneration.

Authors:  Chao Wan; Shawn R Gilbert; Ying Wang; Xuemei Cao; Xing Shen; Girish Ramaswamy; Kimberly A Jacobsen; Zainab S Alaql; Alan W Eberhardt; Louis C Gerstenfeld; Thomas A Einhorn; Lianfu Deng; Thomas L Clemens
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-09       Impact factor: 11.205
View more
  29 in total

1.  In vitro and in vivo inhibition of mTOR by 1,25-dihydroxyvitamin D3 to improve early diabetic nephropathy via the DDIT4/TSC2/mTOR pathway.

Authors:  Hang Wang; Jianmin Wang; Hua Qu; Huili Wei; Baolan Ji; Zesong Yang; Jing Wu; Qin He; Yuanyuan Luo; Dan Liu; Yang Duan; Fang Liu; Huacong Deng
Journal:  Endocrine       Date:  2016-07-09       Impact factor: 3.633

2.  A switch between cytoprotective and cytotoxic autophagy in the radiosensitization of breast tumor cells by chloroquine and vitamin D.

Authors:  Eden N Wilson; Molly L Bristol; Xu Di; William A Maltese; Kristen Koterba; Matthew J Beckman; David A Gewirtz
Journal:  Horm Cancer       Date:  2011-10       Impact factor: 3.869

3.  Calcitriol Reverses the Down-Regulation Pattern of Tuberous Sclerosis Complex Genes in an In Vitro Calcification Model.

Authors:  Eraldo Fonseca Dos Santos Junior; Roberta Rodrigues de Lemos Gitirana; Darlene Paiva Bezerra; João Ricardo Mendes de Oliveira
Journal:  J Mol Neurosci       Date:  2017-12-11       Impact factor: 3.444

Review 4.  Vitamin D, immune tolerance, and prevention of type 1 diabetes.

Authors:  Klaus Badenhoop; Heinrich Kahles; Marissa Penna-Martinez
Journal:  Curr Diab Rep       Date:  2012-12       Impact factor: 4.810

5.  The Combination of the CDK4/6 Inhibitor, Palbociclib, With the Vitamin D3 Analog, Inecalcitol, Has Potent In Vitro and In Vivo Anticancer Effects in Hormone-Sensitive Breast Cancer, But Has a More Limited Effect in Triple-Negative Breast Cancer.

Authors:  Justine Vanhevel; Lieve Verlinden; Shauni Loopmans; Stefanie Doms; Iris Janssens; Sien Bevers; Steve Stegen; Hans Wildiers; Annemieke Verstuyf
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-17       Impact factor: 6.055

6.  Ectopic NGAL expression can alter sensitivity of breast cancer cells to EGFR, Bcl-2, CaM-K inhibitors and the plant natural product berberine.

Authors:  William H Chappell; Stephen L Abrams; Richard A Franklin; Michelle M LaHair; Giuseppe Montalto; Melchiorre Cervello; Alberto M Martelli; Ferdinando Nicoletti; Saverio Candido; Massimo Libra; Jerry Polesel; Renato Talamini; Michele Milella; Agostino Tafuri; Linda S Steelman; James A McCubrey
Journal:  Cell Cycle       Date:  2012-11-16       Impact factor: 4.534

7.  Vitamin D3 Inhibits Wnt/β-Catenin and mTOR Signaling Pathways in Human Uterine Fibroid Cells.

Authors:  Ayman Al-Hendy; Michael P Diamond; Thomas G Boyer; Sunil K Halder
Journal:  J Clin Endocrinol Metab       Date:  2016-01-28       Impact factor: 5.958

8.  Attenuation of constitutive DNA damage signaling by 1,25-dihydroxyvitamin D3.

Authors:  H Dorota Halicka; Hong Zhao; Jiangwei Li; Frank Traganos; George P Studzinski; Zbigniew Darzynkiewicz
Journal:  Aging (Albany NY)       Date:  2012-04       Impact factor: 5.682

Review 9.  Mutations and deregulation of Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascades which alter therapy response.

Authors:  James A McCubrey; Linda S Steelman; William H Chappell; Stephen L Abrams; Giuseppe Montalto; Melchiorre Cervello; Ferdinando Nicoletti; Paolo Fagone; Grazia Malaponte; Maria C Mazzarino; Saverio Candido; Massimo Libra; Jörg Bäsecke; Sanja Mijatovic; Danijela Maksimovic-Ivanic; Michele Milella; Agostino Tafuri; Lucio Cocco; Camilla Evangelisti; Francesca Chiarini; Alberto M Martelli
Journal:  Oncotarget       Date:  2012-09

Review 10.  Advances in targeting signal transduction pathways.

Authors:  James A McCubrey; Linda S Steelman; William H Chappell; Lin Sun; Nicole M Davis; Stephen L Abrams; Richard A Franklin; Lucio Cocco; Camilla Evangelisti; Francesca Chiarini; Alberto M Martelli; Massimo Libra; Saverio Candido; Giovanni Ligresti; Grazia Malaponte; Maria C Mazzarino; Paolo Fagone; Marco Donia; Ferdinando Nicoletti; Jerry Polesel; Renato Talamini; Jörg Bäsecke; Sanja Mijatovic; Danijela Maksimovic-Ivanic; Michele Michele; Agostino Tafuri; Joanna Dulińska-Litewka; Piotr Laidler; Antonio B D'Assoro; Lyudmyla Drobot; Drobot Umezawa; Giuseppe Montalto; Melchiorre Cervello; Zoya N Demidenko
Journal:  Oncotarget       Date:  2012-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.